Macleods Pharmaceuticals Limited Pyrazinamide Export Data — India (DGFT 2022–2026)

Name: Macleods Pharmaceuticals Limited Pyrazinamide Export Records India — #3 Exporter, 143 Shipments, $7.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Pyrazinamide

India Pharmaceutical Trade Intelligence

$962.4M90 Suppliers131 CountriesHS 30049057

ExportsIndia → CONGO DR55.5%India → NIGERIA26.0%

ImportsUNITED STATES → India$5.0K GERMANY → India$2.6K

#1 Supplier: LUPIN LIMITED #1 Buyer: NATIONAL TUBERCULOSIS

Macleods Pharmaceuticals Limited — Pyrazinamide Exporter #3 | $25.2M Trade Value | TransData Nexus | TransData Nexus

Macleods Pharmaceuticals Limited — Pyrazinamide Exporter Profile

Indian Pharmaceutical Exporter · #3 for Pyrazinamide · $25.2M export value · DGFT Verified

Macleods Pharmaceuticals Limited is the #3 Indian exporter of Pyrazinamide with $25.2M in export value and 143 verified shipments. Macleods Pharmaceuticals Limited holds a 1.9% market share in Pyrazinamide exports across 51 countries. The company exports 64 pharmaceutical products worth $589.8M across 20 therapeutic categories.

Macleods Pharmaceuticals Limited — Pyrazinamide Export Profile: Buyers & Destinations

Macleods Pharmaceuticals Limited Pyrazinamide export treemap — buyers and destination countries | TransData Nexus

Where Does Macleods Pharmaceuticals Limited Export Pyrazinamide?

Country	Value	Shipments	Share
SOUTH AFRICA	$1.2M	39	12.6%
NETHERLANDS	$1.2M	54	11.9%
PAKISTAN	$623.0K	15	6.4%
UNITED STATES	$418.6K	24	4.3%

Who Are the Top Buyers of Pyrazinamide from Macleods Pharmaceuticals Limited?

Buyer	Country	Value	Orders
I+SOLUTIONS	NETHERLANDS	$638.4K	33
MACLEODS PHARMACEUTICALS SA	SOUTH AFRICA	$565.0K	16
MACLEODS PHARMACEUTICALS SA (PTY) L	SOUTH AFRICA	$331.9K	16
MACLEODS PHARMA USA INC	UNITED STATES	$288.0K	12
NOUVELLE PSP CI	COTE D IVOIRE	$274.1K	14
IDA FOUNDATION	NETHERLANDS	$257.4K	10
ADVANCED PHARMACEUTICALS LIMITED	RUSSIA	$250.0K	5
IDA FOUNDATION,	NETHERLANDS	$237.7K	9
NATIONAL TB CONTROL PROGRAM,PAKISTA	PAKISTAN	$223.0K	7
NATIONAL TB CONTROL PROGRAMME, PAKI	PAKISTAN	$200.0K	4

Macleods Pharmaceuticals Limited supplies Pyrazinamide to 176 buyers globally. The largest buyer is I+SOLUTIONS (NETHERLANDS), followed by MACLEODS PHARMACEUTICALS SA (SOUTH AFRICA) and MACLEODS PHARMACEUTICALS SA (PTY) L (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Pyrazinamide Formulations Does Macleods Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
RIFAMPICIN 75MG/ISONIAZID 50MG/ PYRAZINAMIDE 150MG DISPERSIBLE TABLETS,PACK 63,975 (PACK SIZE 3 X 28 TABS)NOS	$150.0K	3
RIFAMPICIN 75MG/ISONIAZID 50MG/PYRAZINAMIDE 150MG DISPERSIBLE TABLETS BNO.NRU2449A, NRU2450A MD.11/24 ED.10/26 PS:3X28S	$150.0K	3
PATIENT KIT(FORECOX TRAC) (RIFAMPICIN 150MG+ISONIAZID 75MG+PYRAZINAMIDE 400MG+ETHAMBUTOL 275MG TABLETS USP)NOS	$150.0K	3
RIFAMPICIN 150MG/ ISONIAZID 75MG /PYRAZINAMIDE 400MG/ ETHAMBUTOL HCL 275MG TABLETS ( 3672 X 24 X28S) DRUGS AND PHARMACENOS	$150.0K	3
DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES RIFAMPICIN ISONIAZID AND PYRAZINAMIDE TABLETS (150MG+150MG+375 MG)NOS	$150.0K	3
MEDICINES. RIFAMPICIN 150MG + ISONIAZID 75MG + PYRAZINAMIDE 400MG + ETHAMBUTOL 275MG TABLETS	$150.0K	3
RIFAMPICIN 150MG/ISONIAZID 75MG/PYRAZINAMIDE 400/ETHAMBUTOL 275MG TABLET PS: 24X28S BNO:NRG23110C MD.12/23 ED.11/26****	$146.5K	3
RIFAMPICIN 75MG / ISONIAZID 50MG / PYRAZINAMIDE 150MG DISPERSIBLE TABLETS	$144.0K	3
DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES RIFAMPICIN ISONIAZID PYRAZINAMIDE AND ETHAMBUTOL HYDROCHLORIDE TABLETS USP	$138.3K	4
RIFAMPICIN 75MG/ISONIAZID 50MG/PYRAZINAMIDE 150MG DISPERSIBLE TAB.,B/N:NRU2403A/NRU2405A/NRU2404A,M.D.JAN-24,E.D.DEC-25	$132.7K	3

Macleods Pharmaceuticals Limited exports 333 distinct Pyrazinamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RIFAMPICIN 75MG/ISONIAZID 50MG/ PYRAZINAMIDE 150MG DISPERSIB with 3 shipments worth $150.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Macleods Pharmaceuticals Limited Compare to Nearest Pyrazinamide Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	MACLEODS PHARMACEUTICALS LTD	$18.1M	361	84	$50.0K
1	LUPIN LIMITED	$16.1M	321	49	$50.0K
3	MACLEODS PHARMACEUTICALS LIMITED ★	$7.2M	143	51	$50.0K
4	MANEESH PHARMACEUTICALS LIMITED	$3.5M	69	24	$50.0K
5	SVIZERA LABS PRIVATE LIMITED	$1.9M	39	12	$50.0K

Macleods Pharmaceuticals Limited ranks #3 among 90 Indian Pyrazinamide exporters. Average shipment value of $50.0K compared to the market average of $557.3K. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and LUPIN LIMITED.

Which Indian Ports Ship Pyrazinamide Exports?

Port	Shipments	% Share
SAHAR AIR	357	24.5%
SAHAR AIR CARGO ACC (INBOM4)	170	11.7%
DELHI AIR	154	10.6%
DELHI AIR CARGO ACC (INDEL4)	126	8.6%
Bombay Air	94	6.4%
NHAVA SHEVA SEA (INNSA1)	87	6.0%
JNPT	87	6.0%
JNPT/ NHAVA SHEVA SEA	81	5.6%

Geopolitical & Trade Policy Impact on Macleods Pharmaceuticals Limited's Pyrazinamide Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Macleods Pharmaceuticals. The Israel-Iran tensions have escalated security risks in the Red Sea and Strait of Hormuz, leading to increased shipping costs and extended transit times. Major carriers have rerouted vessels around the Cape of Good Hope, adding 10–20 days to shipments and raising freight rates by 40–50% on key India–Europe routes. (livemint.com)

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. However, potential U.S. tariffs on Indian pharmaceutical imports pose a significant risk. A 25% tariff could render many low-margin generic drugs unprofitable, compelling companies to scale back operations or exit certain product segments, thereby exacerbating drug shortages in the U.S. (cfo.economictimes.indiatimes.com)

The recent India–European Union Free Trade Agreement, signed in January 2026, offers a favorable development by eliminating tariffs on most pharmaceutical products. This agreement is expected to enhance the competitiveness of Indian exporters in the EU market, providing a counterbalance to challenges in other regions. (en.wikipedia.org)

Macleods Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a cornerstone for Indian pharmaceutical exporters. Macleods Pharmaceuticals' recent recalls in the U.S. market, including the Famciclovir tablet recall due to contamination, highlight the critical need for stringent adherence to Good Manufacturing Practices (GMP). Such incidents can tarnish a company's reputation and impede market access. (pharma.economictimes.indiatimes.com)

The evolving regulatory landscape, including the EU's Falsified Medicines Directive, necessitates robust serialization and traceability measures. Indian exporters must invest in advanced compliance systems to meet these requirements, ensuring product integrity and sustaining export growth.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Pyrazinamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Macleods Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 504 individual customs records matching Macleods Pharmaceuticals Limited exporting Pyrazinamide, covering 333 formulations to 104 countries via 176 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 131+ countries, 434+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Pyrazinamide

Pyrazinamide

Macleods Pharmaceuticals Limited — Pyrazinamide Exporter Profile

Macleods Pharmaceuticals Limited — Pyrazinamide Export Profile: Buyers & Destinations

Where Does Macleods Pharmaceuticals Limited Export Pyrazinamide?

Who Are the Top Buyers of Pyrazinamide from Macleods Pharmaceuticals Limited?

What Is India's Total Pyrazinamide Export Value and How Much Does Macleods Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Macleods Pharmaceuticals Limited's Pyrazinamide Exports?

How Does Macleods Pharmaceuticals Limited Compare to Other Indian Pyrazinamide Exporters?

What Pyrazinamide Formulations Does Macleods Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Pyrazinamide to Key Markets

South Africa — SAHPRA

How Does Macleods Pharmaceuticals Limited Compare to Nearest Pyrazinamide Exporters?

Which Indian Ports Ship Pyrazinamide Exports?

What Other Tuberculosis Medications Products Does Macleods Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Macleods Pharmaceuticals Limited's Pyrazinamide Exports

Macleods Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Macleods Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Pyrazinamide Export Data from Macleods Pharmaceuticals Limited

Pyrazinamide Stats

Company Overview

Top Products by Macleods Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source